- Home
- LBTYA vs PRCT Comparison
LBTYA vs PRCT Comparison
Compare LBTYA & PRCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LBTYA
- PRCT
- Stock Information
- Founded
- LBTYA 2004
- PRCT 2009
- Country
- LBTYA Bermuda
- PRCT United States
- Employees
- LBTYA N/A
- PRCT N/A
- Industry
- LBTYA Cable & Other Pay Television Services
- PRCT Medical Specialities
- Sector
- LBTYA Telecommunications
- PRCT Health Care
- Exchange
- LBTYA Nasdaq
- PRCT Nasdaq
- Market Cap
- LBTYA 3.6B
- PRCT 3.2B
- IPO Year
- LBTYA N/A
- PRCT 2021
- Fundamental
- Price
- LBTYA $9.63
- PRCT $58.00
- Analyst Decision
- LBTYA Buy
- PRCT Strong Buy
- Analyst Count
- LBTYA 5
- PRCT 7
- Target Price
- LBTYA $15.92
- PRCT $90.00
- AVG Volume (30 Days)
- LBTYA 3.2M
- PRCT 850.8K
- Earning Date
- LBTYA 07-24-2025
- PRCT 04-24-2025
- Dividend Yield
- LBTYA 104.37%
- PRCT N/A
- EPS Growth
- LBTYA N/A
- PRCT N/A
- EPS
- LBTYA N/A
- PRCT N/A
- Revenue
- LBTYA $4,421,800,000.00
- PRCT $249,121,000.00
- Revenue This Year
- LBTYA $6.11
- PRCT $47.40
- Revenue Next Year
- LBTYA $0.37
- PRCT $31.81
- P/E Ratio
- LBTYA N/A
- PRCT N/A
- Revenue Growth
- LBTYA 32.44
- PRCT 59.36
- 52 Week Low
- LBTYA $9.03
- PRCT $47.04
- 52 Week High
- LBTYA $21.56
- PRCT $103.81
- Technical
- Relative Strength Index (RSI)
- LBTYA 43.46
- PRCT 54.16
- Support Level
- LBTYA $9.44
- PRCT $55.18
- Resistance Level
- LBTYA $9.91
- PRCT $59.06
- Average True Range (ATR)
- LBTYA 0.29
- PRCT 2.64
- MACD
- LBTYA 0.05
- PRCT 0.16
- Stochastic Oscillator
- LBTYA 53.10
- PRCT 78.08
About LBTYA Liberty Global Ltd.
Liberty Global is a holding company with interests in several telecom companies in the UK, the Netherlands, Belgium, Switzerland, Ireland, and Slovakia. Liberty owns the main cable network in each of these geographies, and has pursued a strategy since 2016 to merge or partner with mobile-network operators to be able to offer converged services. Liberty also owns minority stakes in other media, entertainment, and cloud companies.
About PRCT PROCEPT BioRobotics Corporation
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, which are image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.